Janet Fisher - Publications

Affiliations: 
Medical University of South Carolina, Charleston, SC, United States 
Area:
GABAA biophysics

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Fisher JL. The auxiliary subunits Neto1 and Neto2 have distinct, subunit-dependent effects at recombinant GluK1- and GluK2-containing kainate receptors. Neuropharmacology. 99: 471-480. PMID 26277340 DOI: 10.1016/j.neuropharm.2015.08.018  1
2014 Fisher MT, Fisher JL. Contributions of different kainate receptor subunits to the properties of recombinant homomeric and heteromeric receptors. Neuroscience. 278: 70-80. PMID 25139762 DOI: 10.1016/j.neuroscience.2014.08.009  1
2014 Fisher JL. The neurotoxin domoate causes long-lasting inhibition of the kainate receptor GluK5 subunit. Neuropharmacology. 85: 9-17. PMID 24859608 DOI: 10.1016/j.neuropharm.2014.05.003  1
2013 Mott DD, Grosenbaugh DK, Fisher JL. Polytherapy with stiripentol: consider more than just metabolic interactions. Epilepsy & Behavior : E&B. 29: 585. PMID 24094845 DOI: 10.1016/j.yebeh.2013.09.008  1
2013 Fisher JL, Housley PR. Agonist binding to the GluK5 subunit is sufficient for functional surface expression of heteromeric GluK2/GluK5 kainate receptors. Cellular and Molecular Neurobiology. 33: 1099-108. PMID 23975096 DOI: 10.1007/s10571-013-9976-x  1
2013 Heidelberg LS, Warren JW, Fisher JL. SB-205384 is a positive allosteric modulator of recombinant GABAA receptors containing rat α3, α5, or α6 subunit subtypes coexpressed with β3 and γ2 subunits. The Journal of Pharmacology and Experimental Therapeutics. 347: 235-41. PMID 23902941 DOI: 10.1124/jpet.113.207324  1
2013 Fisher JL, Mott DD. Modulation of homomeric and heteromeric kainate receptors by the auxiliary subunit Neto1. The Journal of Physiology. 591: 4711-24. PMID 23798491 DOI: 10.1113/jphysiol.2013.256776  1
2012 Fisher JL, Mott DD. The auxiliary subunits Neto1 and Neto2 reduce voltage-dependent inhibition of recombinant kainate receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 12928-33. PMID 22973017 DOI: 10.1523/JNEUROSCI.2211-12.2012  1
2012 Alexeev M, Grosenbaugh DK, Mott DD, Fisher JL. The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABA(A) receptors. Neuropharmacology. 62: 2507-14. PMID 22445602 DOI: 10.1016/j.neuropharm.2012.03.002  1
2011 Leahy JT, Chu-Shore CJ, Fisher JL. Clobazam as an adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome. Neuropsychiatric Disease and Treatment. 7: 673-81. PMID 22128252 DOI: 10.2147/NDT.S20173  1
2011 Fisher JL, Mott DD. Distinct functional roles of subunits within the heteromeric kainate receptor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 17113-22. PMID 22114280 DOI: 10.1523/JNEUROSCI.3685-11.2011  1
2011 Bianchi MT, Clark AG, Fisher JL. The wake-promoting transmitter histamine preferentially enhances α-4 subunit-containing GABAA receptors. Neuropharmacology. 61: 747-52. PMID 21640733 DOI: 10.1016/j.neuropharm.2011.05.020  1
2011 Fisher JL. The effects of stiripentol on GABA(A) receptors. Epilepsia. 52: 76-8. PMID 21463286 DOI: 10.1111/j.1528-1167.2011.03008.x  1
2011 Lee CY, Perez FM, Wang W, Guan X, Zhao X, Fisher JL, Guan Y, Sweitzer SM, Raja SN, Tao YX. Dynamic temporal and spatial regulation of mu opioid receptor expression in primary afferent neurons following spinal nerve injury. European Journal of Pain (London, England). 15: 669-75. PMID 21310637 DOI: 10.1016/j.ejpain.2010.11.018  1
2011 Fisher JL. Interactions between modulators of the GABA(A) receptor: Stiripentol and benzodiazepines. European Journal of Pharmacology. 654: 160-5. PMID 21237147 DOI: 10.1016/j.ejphar.2010.12.037  1
2010 Fisher MT, Fisher JL. Activation of alpha6-containing GABAA receptors by pentobarbital occurs through a different mechanism than activation by GABA. Neuroscience Letters. 471: 195-9. PMID 20109529 DOI: 10.1016/j.neulet.2010.01.041  1
2010 Mott DD, Rojas A, Fisher JL, Dingledine RJ, Benveniste M. Subunit-specific desensitization of heteromeric kainate receptors. The Journal of Physiology. 588: 683-700. PMID 20026616 DOI: 10.1113/jphysiol.2009.185207  1
2009 Nimmich ML, Heidelberg LS, Fisher JL. RNA editing of the GABA(A) receptor alpha3 subunit alters the functional properties of recombinant receptors. Neuroscience Research. 63: 288-93. PMID 19367790 DOI: 10.1016/j.neures.2009.01.003  1
2009 Fisher JL. The anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulator. Neuropharmacology. 56: 190-7. PMID 18585399 DOI: 10.1016/j.neuropharm.2008.06.004  1
2007 Bianchi MT, Botzolakis EJ, Haas KF, Fisher JL, Macdonald RL. Microscopic kinetic determinants of macroscopic currents: insights from coupling and uncoupling of GABAA receptor desensitization and deactivation. The Journal of Physiology. 584: 769-87. PMID 17884921 DOI: 10.1113/jphysiol.2007.142364  1
2007 Picton AJ, Fisher JL. Effect of the alpha subunit subtype on the macroscopic kinetic properties of recombinant GABA(A) receptors. Brain Research. 1165: 40-9. PMID 17658489 DOI: 10.1016/j.brainres.2007.06.050  1
2006 Drafts BC, Fisher JL. Identification of structures within GABAA receptor alpha subunits that regulate the agonist action of pentobarbital. The Journal of Pharmacology and Experimental Therapeutics. 318: 1094-101. PMID 16728592 DOI: 10.1124/jpet.106.104844  1
2004 Fisher JL. The alpha 1 and alpha 6 subunit subtypes of the mammalian GABA(A) receptor confer distinct channel gating kinetics. The Journal of Physiology. 561: 433-48. PMID 15579538 DOI: 10.1113/jphysiol.2003.051839  1
2004 Fisher JL. A mutation in the GABAA receptor alpha 1 subunit linked to human epilepsy affects channel gating properties. Neuropharmacology. 46: 629-37. PMID 14996540 DOI: 10.1016/j.neuropharm.2003.11.015  1
2004 Drafts BC, Fisher JL. Structural determinants of the pharmacological properties of the GABAA receptor alpha6 subunit. The Journal of Pharmacology and Experimental Therapeutics. 309: 1108-15. PMID 14762104 DOI: 10.1124/jpet.103.064360  1
2003 Robinson RT, Drafts BC, Fisher JL. Fluoxetine increases GABA(A) receptor activity through a novel modulatory site. The Journal of Pharmacology and Experimental Therapeutics. 304: 978-84. PMID 12604672 DOI: 10.1124/jpet.102.044834  1
2002 Fisher JL. A lysine residue in the beta3 subunit contributes to the regulation of GABA(A) receptor activity by voltage. Molecular and Cellular Neurosciences. 20: 683-94. PMID 12213448 DOI: 10.1006/mcne.2002.1143  1
2002 Fisher JL. A histidine residue in the extracellular N-terminal domain of the GABA(A) receptor alpha5 subunit regulates sensitivity to inhibition by zinc. Neuropharmacology. 42: 922-8. PMID 12069902 DOI: 10.1016/S0028-3908(02)00050-3  1
2002 Fisher JL. Amiloride inhibition of gamma-aminobutyric acid(A) receptors depends upon the alpha subunit subtype. Molecular Pharmacology. 61: 1322-8. PMID 12021393 DOI: 10.1124/mol.61.6.1322  1
2000 Fisher JL, Dani JA. Nicotinic receptors on hippocampal cultures can increase synaptic glutamate currents while decreasing the NMDA-receptor component. Neuropharmacology. 39: 2756-69. PMID 11044745 DOI: 10.1016/S0028-3908(00)00102-7  1
2000 Fisher JL, Hinkle DJ, Macdonald RL. Loreclezole inhibition of recombinant alpha1beta1gamma2L GABA(A) receptor single channel currents. Neuropharmacology. 39: 235-45. PMID 10670419 DOI: 10.1016/S0028-3908(99)00108-2  1
1999 Radcliffe KA, Fisher JL, Gray R, Dani JA. Nicotinic modulation of glutamate and GABA synaptic transmission of hippocampal neurons. Annals of the New York Academy of Sciences. 868: 591-610. PMID 10414340 DOI: 10.1111/j.1749-6632.1999.tb11332.x  1
1999 Neelands TR, Fisher JL, Bianchi M, Macdonald RL. Spontaneous and gamma-aminobutyric acid (GABA)-activated GABA(A) receptor channels formed by epsilon subunit-containing isoforms. Molecular Pharmacology. 55: 168-78. PMID 9882711  1
1998 Fisher JL, Pidoplichko VI, Dani JA. Nicotine modifies the activity of ventral tegmental area dopaminergic neurons and hippocampal GABAergic neurons. Journal of Physiology, Paris. 92: 209-13. PMID 9789810 DOI: 10.1016/S0928-4257(98)80012-0  1
1998 Fisher JL, Macdonald RL. The role of an alpha subtype M2-M3 His in regulating inhibition of GABAA receptor current by zinc and other divalent cations. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 2944-53. PMID 9526011  1
1997 Fisher JL, Macdonald RL. Functional properties of recombinant GABA(A) receptors composed of single or multiple beta subunit subtypes. Neuropharmacology. 36: 1601-10. PMID 9517431 DOI: 10.1016/S0028-3908(97)00133-0  1
1997 Fisher JL, Macdonald RL. Single channel properties of recombinant GABAA receptors containing gamma 2 or delta subtypes expressed with alpha 1 and beta 3 subtypes in mouse L929 cells. The Journal of Physiology. 505: 283-97. PMID 9423172 DOI: 10.1111/j.1469-7793.1997.283bb.x  1
1997 Fisher JL, Zhang J, Macdonald RL. The role of alpha1 and alpha6 subtype amino-terminal domains in allosteric regulation of gamma-aminobutyric acida receptors. Molecular Pharmacology. 52: 714-24. PMID 9380035  1
Show low-probability matches.